WO2004056961A9 - Methods of identifying compounds that modulate protein activity - Google Patents
Methods of identifying compounds that modulate protein activity Download PDFInfo
- Publication number
- WO2004056961A9 WO2004056961A9 PCT/US2003/034114 US0334114W WO2004056961A9 WO 2004056961 A9 WO2004056961 A9 WO 2004056961A9 US 0334114 W US0334114 W US 0334114W WO 2004056961 A9 WO2004056961 A9 WO 2004056961A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- protein activity
- identifying compounds
- modulate protein
- modulate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003287228A AU2003287228A1 (en) | 2002-10-25 | 2003-10-27 | Methods of identifying compounds that modulate protein activity |
Applications Claiming Priority (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42123902P | 2002-10-25 | 2002-10-25 | |
US60/421,239 | 2002-10-25 | ||
US42170002P | 2002-10-28 | 2002-10-28 | |
US60/421,700 | 2002-10-28 | ||
US42277602P | 2002-10-31 | 2002-10-31 | |
US60/422,776 | 2002-10-31 | ||
US42619702P | 2002-11-13 | 2002-11-13 | |
US60/426,197 | 2002-11-13 | ||
US43556802P | 2002-12-20 | 2002-12-20 | |
US43549802P | 2002-12-20 | 2002-12-20 | |
US43551002P | 2002-12-20 | 2002-12-20 | |
US60/435,498 | 2002-12-20 | ||
US60/435,568 | 2002-12-20 | ||
US60/435,510 | 2002-12-20 | ||
US45681203P | 2003-03-21 | 2003-03-21 | |
US60/456,812 | 2003-03-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004056961A2 WO2004056961A2 (en) | 2004-07-08 |
WO2004056961A9 true WO2004056961A9 (en) | 2010-01-21 |
Family
ID=32686455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/034114 WO2004056961A2 (en) | 2002-10-25 | 2003-10-27 | Methods of identifying compounds that modulate protein activity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003287228A1 (en) |
WO (1) | WO2004056961A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20050640A0 (en) * | 2005-06-16 | 2005-06-16 | Faron Pharmaceuticals Oy | Compounds for treating or preventing diseases or disorders related to amine oxidases |
-
2003
- 2003-10-27 WO PCT/US2003/034114 patent/WO2004056961A2/en not_active Application Discontinuation
- 2003-10-27 AU AU2003287228A patent/AU2003287228A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003287228A8 (en) | 2010-02-11 |
WO2004056961A2 (en) | 2004-07-08 |
AU2003287228A1 (en) | 2004-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003209060A1 (en) | Assay for acytyltransferase or deacetylase activity | |
AU2002316137A1 (en) | Method of determining protein interaction inhibitors | |
AU2002362030A1 (en) | Methods for inhibiting deacetylase activity | |
AU2003299592A1 (en) | Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 | |
AU2003252072A1 (en) | Modulation of protein kinase c-iota expression | |
AU2002364124A1 (en) | Methods for identifying modulators of apoptosis | |
AU2003297700A1 (en) | METHODS FOR MODULATING IKKAlpha ACTIVITY | |
AU2003282338A1 (en) | Determination of protein function | |
AU2003241375A1 (en) | Method for identifying modulators of sulfotransferase activity | |
EP1497450A4 (en) | Methods for identifying compounds that modulate enzymatic activity | |
AU2003217174A1 (en) | Novel variants of rankl protein | |
WO2004056961A9 (en) | Methods of identifying compounds that modulate protein activity | |
WO2006020326A9 (en) | Methods of identifying compounds that modulate protein activity | |
AU2003297808A1 (en) | Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides | |
EP1537239A4 (en) | Methods of identifying compounds that modulate protein activity | |
AU2003243756A1 (en) | Source of record manager | |
AU2003303381A1 (en) | Methods for treating malaria by modulation of g protein function | |
AU2003293382A1 (en) | Methods for identifying the activity of gene products | |
AU2002245613A1 (en) | Methods and reagents for identifying compounds and mutations that modulate dopamine beta-hydroxylase activity | |
AU2003202694A1 (en) | Torero protein | |
AU2003206594A1 (en) | Screening for modulators of pkng activity | |
AU2003256701A1 (en) | Methods of modulating proliferative conditions | |
AU2003241335A1 (en) | Method of analyzing ataxia-telangiectasia protein | |
AU2003293581A1 (en) | Method of identifying therapeutic agents | |
AU2003218029A1 (en) | Methods of identifying target polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |